Emergency Medicine
Critical Care
Nephrology
Emergency
High Evidence

Rhabdomyolysis

Rhabdomyolysis represents a clinical syndrome ranging from asymptomatic CK elevation to life-threatening multi-organ fai... ACEM Fellowship Written, ACEM Fellow

Updated 24 Jan 2026
44 min read

Clinical board

A visual summary of the highest-yield teaching signals on this page.

Urgent signals

Safety-critical features pulled from the topic metadata.

  • CK greater than 40,000 U/L - high risk AKI requiring dialysis
  • Hyperkalemia greater than 6.5 mEq/L with ECG changes - cardiac arrest risk
  • Anuria or oliguria despite fluid resuscitation
  • Compartment syndrome - pain out of proportion, tense limb

Exam focus

Current exam surfaces linked to this topic.

  • ACEM Fellowship Written
  • ACEM Fellowship OSCE

Linked comparisons

Differentials and adjacent topics worth opening next.

  • Acute Kidney Injury
  • Hyperkalemia

Editorial and exam context

ACEM Fellowship Written
ACEM Fellowship OSCE

Topic family

This concept exists in multiple MedVellum libraries. Use the primary page for the broadest reference view and the others for exam-specific framing.

Clinical reference article

Quick Answer

One-liner: Rhabdomyolysis is the breakdown of skeletal muscle releasing intracellular contents (myoglobin, CK, potassium, phosphate) into the circulation, causing AKI, life-threatening hyperkalemia, and multi-organ dysfunction - treated primarily with aggressive IV fluid resuscitation targeting urine output 200-300 mL/hr.

Rhabdomyolysis represents a clinical syndrome ranging from asymptomatic CK elevation to life-threatening multi-organ failure. The triad of muscle pain, weakness, and dark urine is classic but present in only 50% of cases [1]. Mortality ranges from 5-10% overall but increases to 20-50% when complicated by acute kidney injury (AKI), which occurs in 15-33% of cases [2]. Early recognition and aggressive crystalloid resuscitation is the cornerstone of management, with the goal of preventing myoglobin-induced nephrotoxicity through high tubular flow rates.


ACEM Exam Focus

Primary Exam Relevance

  • Anatomy: Skeletal muscle ultrastructure, sarcoplasmic reticulum, sarcolemma
  • Physiology: Muscle contraction (excitation-contraction coupling), ATP-dependent calcium regulation, myoglobin oxygen binding
  • Pharmacology: Dantrolene (sarcoplasmic reticulum calcium release blocker), diuretics, bicarbonate pharmacokinetics

Fellowship Exam Relevance

  • Written: Classification of causes (crush, exertional, drug-induced, hyperthermia), McMahon score for prognosis, dialysis indications, bicarbonate controversy
  • OSCE: Fluid resuscitation management, hyperkalemia treatment, compartment syndrome assessment, breaking bad news for dialysis requirement
  • Key domains tested: Medical Expert, Collaborator (nephrology liaison, surgical consult for fasciotomy)

Key Points

Clinical Pearl

The 5 things you MUST know:

  1. CK greater than 5x ULN (greater than 1,000 U/L) defines rhabdomyolysis; CK greater than 15,000 U/L significantly increases AKI risk; CK greater than 40,000 U/L is high-risk for dialysis/death
  2. Aggressive IV crystalloid is the cornerstone of treatment: target urine output 200-300 mL/hr (2-3 mL/kg/hr) with isotonic crystalloid (NS or Ringer's lactate)
  3. Hyperkalemia is the most immediately life-threatening complication - can cause cardiac arrest before AKI develops
  4. Sodium bicarbonate is NOT routinely recommended - systematic reviews show no benefit over crystalloid alone for preventing AKI
  5. Treat the underlying cause - stop offending drugs, cool hyperthermia, consider dantrolene for MH/NMS, urgent fasciotomy for compartment syndrome

Epidemiology

MetricValueSource
Incidence~26,000 cases/year (Australia)[1]
AKI incidence15-33% of rhabdomyolysis cases[2]
Mortality (overall)5-10%[3]
Mortality (with AKI)20-50%[4]
Peak age20-50 years[5]
Gender ratioM:F 2:1[6]

Australian/NZ Specific Data

  • Higher rates of exertional rhabdomyolysis in military personnel, athletes, and manual laborers in hot climates [7]
  • Drug-induced causes account for 25-30% of cases (statins, illicit drugs, psychotropics) [8]
  • Aboriginal and Torres Strait Islander populations experience higher rates of AKI requiring RRT, with delayed access to dialysis services in remote communities [9,10]
  • Māori in New Zealand have 2-3x higher age-standardized AKI incidence compared to European New Zealanders [11]

Pathophysiology

Mechanism of Muscle Injury

The fundamental pathophysiology involves disruption of skeletal muscle cell membrane integrity (sarcolemma) leading to:

  1. ATP depletion → Failure of Na+/K+-ATPase and Ca2+-ATPase pumps
  2. Intracellular calcium accumulation → Sustained muscle contraction, protease activation
  3. Cellular necrosis → Release of intracellular contents

Released Substances and Their Effects

SubstanceNormal LevelReleasedClinical Effect
Myoglobin<85 ng/mLUp to 4000xNephrotoxicity, dark urine
Creatine kinase<200 U/LUp to 1000xMarker of injury
Potassium3.5-5.0 mEq/LMassive releaseCardiac arrhythmia
Phosphate0.8-1.4 mmol/LElevatedBinds calcium, worsens hypocalcemia
PurinesNormalElevatedUric acid, worsens AKI

Pathological Progression: Myoglobin-Induced AKI

Muscle Injury → Myoglobin Release → Renal Filtration → Three Mechanisms of Injury:

1. VASOCONSTRICTION
   Myoglobin scavenges nitric oxide → Renal vasoconstriction → Ischemia

2. DIRECT TUBULAR TOXICITY  
   Myoglobin → Ferryl-myoglobin (Fe4+) → Lipid peroxidation → Tubular necrosis

3. CAST FORMATION
   Acidic urine + Tamm-Horsfall protein + Myoglobin → Obstructing casts

Why Acidosis Worsens Injury

In acidic urine (pH <5.6):

  • Myoglobin precipitates with Tamm-Horsfall protein forming obstructive casts [12]
  • Heme iron undergoes enhanced redox cycling generating reactive oxygen species [13]
  • This forms the theoretical basis for urine alkalinization (though clinical benefit unproven) [14]

Aetiology and Classification

Major Causes (Mnemonic: CRUSHED)

CategoryExamplesKey Features
Crush injuryTrauma, entrapment, prolonged immobilizationDisaster medicine, consider compartment syndrome
Recreational drugsCocaine, amphetamines, MDMA, alcoholCommon in Australian ED, often combined with hyperthermia
Uncontrolled exertionIntense exercise, military training, seizuresUsually good prognosis if no comorbidities
Statins and medicationsHMG-CoA reductase inhibitors, antipsychotics, fibratesCheck drug interactions, genetic susceptibility
Heat/HyperthermiaHeat stroke, MH, NMS, serotonin syndromeTemperature greater than 40°C, requires specific treatment
Electrocution/BurnsLightning, electrical injuryExtent may be underestimated
Disease statesMyopathies, infections (influenza, COVID-19), DKAConsider underlying muscle disorder

Exertional Rhabdomyolysis

  • Risk factors: Heat, humidity, dehydration, unaccustomed exercise, sickle cell trait [15]
  • Generally excellent prognosis with early recognition and treatment
  • Common in CrossFit, military training, marathon runners [16]

Drug-Induced Rhabdomyolysis

Drug ClassMechanismRisk Factors
StatinsMitochondrial dysfunction, CoQ10 depletionHigh dose, CYP3A4 inhibitors, renal impairment
AntipsychoticsNMS (dopamine blockade)High potency agents, rapid dose increase
SerotonergicsSerotonin syndromeMAOIs + SSRIs, tramadol combinations
Volatile anestheticsMalignant hyperthermiaRYR1 mutations, succinylcholine
Cocaine/AmphetaminesVasoconstriction, hyperthermia, agitationProlonged use, environmental heat
AlcoholDirect myotoxicity, immobilizationChronic abuse, coma with compression

Hyperthermia Syndromes Causing Rhabdomyolysis

SyndromeTriggerMuscle FindingTreatment
Malignant HyperthermiaVolatile anesthetics, succinylcholineLead-pipe rigidityDantrolene (2.5 mg/kg IV)
Neuroleptic Malignant SyndromeDopamine antagonistsLead-pipe rigidityBromocriptine, dantrolene
Serotonin SyndromeSerotonergic drugsHyperreflexia, clonusCyproheptadine
Heat StrokeEnvironmental/exertionalVariableRapid external cooling

Clinical Approach

Recognition

Suspect rhabdomyolysis in any patient with:

  • Dark "tea-colored" or "cola-colored" urine
  • Muscle pain, tenderness, or swelling (especially after trauma, exertion, or immobilization)
  • Unexplained acute kidney injury
  • Hyperkalemia with muscle weakness
  • History of prolonged immobilization, seizures, or illicit drug use

Initial Assessment

Primary Survey

  • A: Usually patent unless severe hyperthermia with altered consciousness
  • B: Assess for aspiration (immobilized patient), metabolic acidosis (Kussmaul breathing)
  • C: Hypovolemia common (third-spacing into damaged muscle); cardiac monitoring for hyperkalemia
  • D: GCS may be decreased in severe hyperkalemia, hyperthermia syndromes, or intoxication
  • E: Temperature (hyperthermia?), examine muscle compartments, check for crush injury/trauma

History

Key Questions

QuestionSignificance
Duration of immobilization/entrapment?Crush syndrome risk, compartment syndrome
Recent intense exercise or seizure activity?Exertional rhabdo, status epilepticus
Current medications (statins, antipsychotics, serotonergics)?Drug-induced, NMS, serotonin syndrome
Illicit drug use (cocaine, amphetamines, MDMA)?Common ED cause, often with hyperthermia
Recent anesthesia/surgery?Malignant hyperthermia
Family history of muscle disorders or anesthetic reactions?MH susceptibility, metabolic myopathies
Urine color change?Dark urine = myoglobinuria

Red Flag Symptoms

Red Flag
  • Anuria or severe oliguria despite fluid resuscitation
  • ECG changes of hyperkalemia (peaked T waves, QRS widening)
  • Severe limb pain with tense compartments (pain on passive stretch)
  • Temperature greater than 40°C with altered mental status and rigidity
  • Rapidly rising potassium (greater than 0.5 mEq/L/hr)

Examination

General Inspection

  • Level of consciousness (hyperkalemia, hyperthermia, intoxication)
  • Skin: Diaphoresis, mottling, evidence of trauma
  • Urine bag: Dark discoloration (myoglobinuria)

Specific Findings

SystemFindingSignificance
MuscularTenderness, swelling, weaknessIndicates muscle groups affected
LimbsTense compartments, pain on passive stretchCompartment syndrome - surgical emergency
NeurologicalLead-pipe rigidityNMS, MH
Hyperreflexia, clonus, tremorSerotonin syndrome
Temperaturegreater than 40°CMH, NMS, SS, heat stroke
CardiacBradycardia, irregular rhythmHyperkalemia
Fluid statusDehydration, hypotensionThird-spacing into damaged muscle

Compartment Syndrome Assessment

The "6 Ps" (in order of appearance):

  1. Pain out of proportion to injury (earliest, most sensitive)
  2. Pain on passive stretch of affected muscles
  3. Paresthesia (numbness/tingling)
  4. Paralysis (late sign)
  5. Pallor (late)
  6. Pulselessness (very late - limb often already non-viable)

Clinical Pearl: Palpable pulses do NOT exclude compartment syndrome. Compartment pressure can exceed venous pressure while arterial pressure is maintained.


Investigations

Immediate (Resus Bay)

TestPurposeKey Finding
ECGHyperkalemia screeningPeaked T waves → widened QRS → sine wave
VBGK+, pH, lactateK+ greater than 6.0 = urgent; pH <7.2 = severe acidosis
Blood glucoseAssociated hypoglycemia or DKACorrect hypoglycemia
UrinalysisMyoglobinuriaDipstick positive for blood but no RBCs on microscopy

Standard ED Workup

TestIndicationInterpretation
Creatine Kinase (CK)Diagnosis and severitygreater than 1,000 U/L diagnostic; greater than 15,000 U/L high AKI risk; greater than 40,000 U/L critical
Urea, CreatinineBaseline renal functionRising Cr = AKI developing
ElectrolytesK+, PO4, Ca2+, Mg2+Hyperkalemia, hyperphosphatemia, hypocalcemia (early)
FBCInfection, DIC screeningThrombocytopenia suggests DIC
CoagulationDIC screeningPT/aPTT prolonged, low fibrinogen
LFTTransaminases often elevatedAST/ALT from muscle (MM isoform)
Uric acidTumor lysis-like syndromeElevated from purine release
Urine myoglobinConfirm myoglobinuriaOften not available urgently

ECG Changes in Hyperkalemia

K+ Level (mEq/L)ECG FindingUrgency
5.5-6.0Tall peaked T wavesMonitor closely
6.0-6.5Peaked T waves, shortened QTUrgent treatment
6.5-7.5P wave flattening, PR prolongationIV calcium required
7.5-8.0QRS widening, loss of P wavesLife-threatening
greater than 8.0Sine wave patternImminent cardiac arrest

Advanced/Specialist

TestIndicationAvailability
Compartment pressuresSuspected compartment syndrome in obtunded patientMetro/tertiary
MH genetic testingFamily screening after MH eventSpecialist referral
Muscle biopsyRecurrent unexplained rhabdomyolysisNeurology/genetics

Point-of-Care Ultrasound

  • IVC assessment: Guide fluid resuscitation (collapsible IVC = hypovolemic)
  • Cardiac: Assess for hyperkalemic effects if ECG changes present
  • Renal: Baseline kidney size, exclude obstruction
  • Limited role for diagnosis of rhabdomyolysis itself

Risk Stratification

McMahon Score for Predicting AKI Requiring RRT or Death [17]

VariableScoring
Agegreater than 50 years = +2; greater than 70 years = +3
SexFemale = 0; Male = +1
EtiologyNon-exercise-induced = +3
Initial CKgreater than 40,000 U/L = +2
Initial phosphategreater than 1.75 mmol/L = +3
Initial calcium<1.875 mmol/L = +2
Initial bicarbonate<19 mEq/L = +3
Initial creatininegreater than 132.6 umol/L = +3

Interpretation:

ScoreRisk of RRT or Death
<5<3%
7-10~20%
greater than 10greater than 50%

Clinical Application: McMahon score <6 identifies low-risk patients potentially suitable for monitored observation or early discharge with close follow-up [18].


Management

Immediate Management (First 10 Minutes)

1. ASSESS and SECURE (0-2 min)
   - Primary survey (ABCDE)
   - IV access x2 (large bore)
   - Cardiac monitor, continuous SpO2
   - Urgent ECG if any concern for hyperkalemia

2. IDENTIFY HYPERKALEMIA (2-5 min)
   - VBG for K+ (result in &lt;5 min)
   - If ECG changes: Calcium gluconate 10% 10 mL IV over 2-5 min

3. START FLUIDS (5-10 min)
   - Isotonic crystalloid (NS or Hartmann's) 1-2 L bolus
   - Target urine output 200-300 mL/hr (2-3 mL/kg/hr)
   - Insert IDC, strict fluid balance

4. TREAT CAUSE (ongoing)
   - Stop offending drugs
   - Active cooling if hyperthermia greater than 39°C
   - Consider dantrolene if MH/NMS suspected

Hyperkalemia Treatment Algorithm

If K+ greater than 6.5 mEq/L OR any ECG changes:

StepTreatmentMechanismOnsetDuration
1Calcium gluconate 10% 10 mL IV over 2-5 minMembrane stabilization1-3 min30-60 min
2Insulin 10 units + Glucose 50 mL 50% IVK+ shift into cells15-30 min4-6 hrs
3Salbutamol 10-20 mg nebulizedK+ shift into cells15-30 min2-4 hrs
4Sodium bicarbonate 8.4% 50 mL IVK+ shift (if acidotic)30-60 minHours
5DialysisK+ removalImmediateDuration of treatment

Note: Calcium resonium (SPS) has delayed onset (hours) and is NOT useful in acute hyperkalemia management.

Fluid Resuscitation Protocol

First-line: Isotonic crystalloid (Normal Saline 0.9% or Hartmann's solution)

PhaseRateTargetMonitoring
Initial resuscitation1-2 L/hrRestore intravascular volumeBP, HR, UO
Maintenance200-500 mL/hrUO 200-300 mL/hr (2-3 mL/kg/hr)Hourly UO, 4-hourly electrolytes
De-escalationReduce when CK <5,000 U/LAvoid fluid overloadDaily CK, creatinine

Choice of Fluid:

  • Normal Saline: Most commonly used; risk of hyperchloremic acidosis with high volumes [19]
  • Hartmann's/Ringer's Lactate: Balanced crystalloid; may be superior for avoiding acidosis; theoretical concern about potassium content (4 mEq/L) but clinically insignificant [20]
  • Avoid: Dextrose solutions (do not restore intravascular volume), potassium-containing solutions if hyperkalemic

Sodium Bicarbonate: The Controversy

Clinical Pearl

Current Evidence (2024):

  • Systematic reviews show NO proven benefit of sodium bicarbonate over crystalloid alone in preventing AKI [14,21,22]
  • Theoretical benefit: Urine alkalinization (pH greater than 6.5) may reduce myoglobin cast formation and oxidative injury
  • Risks: Hypocalcemia (ionized calcium decreases with alkalosis), metabolic alkalosis, paradoxical intracellular acidosis, fluid overload

When to Consider:

  • Severe systemic metabolic acidosis (pH <7.1)
  • Refractory acidosis despite adequate resuscitation
  • Urine pH remains <6.5 despite crystalloid resuscitation (monitor with urine dipstick)

Do NOT use routinely - crystalloid resuscitation is the primary therapy.

Mannitol

  • Mechanism: Osmotic diuresis, theoretical free radical scavenging
  • Evidence: No RCT evidence of benefit; expert consensus recommends against routine use [21]
  • Risks: Volume depletion if used without adequate crystalloid, osmotic gap, worsens AKI if oliguria
  • Consider only if: Urine output target not achieved despite aggressive hydration AND no evidence of volume depletion

Specific Treatments for Hyperthermia Syndromes

SyndromeTreatmentDoseNotes
Malignant HyperthermiaDantrolene2.5 mg/kg IV, repeat q5-10min to max 10 mg/kgStop trigger, active cooling, monitor for recrudescence
NMSBromocriptine + DantroleneBromocriptine 2.5 mg PO/NGT TDS; Dantrolene as for MHStop dopamine antagonist, supportive care
Serotonin SyndromeCyproheptadine12 mg PO loading, then 2 mg q2h PRNStop serotonergic agents, benzodiazepines for agitation
Heat StrokeAggressive coolingIce packs, evaporative cooling, cold IV fluidsTarget temp <39°C within 30 min

Compartment Syndrome Management

Indications for Fasciotomy:

  • Clinical diagnosis of compartment syndrome
  • Intracompartmental pressure greater than 30 mmHg
  • Delta pressure (diastolic BP - compartment pressure) <30 mmHg in obtunded patient

Timing:

  • Fasciotomy within 6 hours typically results in full recovery
  • Beyond 8-12 hours: Risk of infection and permanent loss of function increases significantly
  • Beyond 24 hours: "Dead limb"
  • fasciotomy may cause sepsis without functional recovery; consider amputation [23]

Dialysis Indications

Standard Indications for RRT in Rhabdomyolysis-Induced AKI (AEIOU)

IndicationThresholdNotes
AcidosispH <7.1 refractory to bicarbonateSevere metabolic acidosis
ElectrolytesK+ greater than 6.5 mEq/L refractory to medical RxMost common urgent indication
IntoxicationDrug overdose requiring removalIf drug amenable to dialysis
OverloadPulmonary edema despite diureticsCannot give more fluid
UremiaEncephalopathy, pericarditis, bleedingSymptomatic uremia

Choice of RRT Modality

ModalityAdvantagesDisadvantages
Intermittent HDRapid K+ removal, widely availableHemodynamic instability
CRRT (CVVHDF)Hemodynamically stable, continuousICU resource, slower correction
Extended daily HD (SLED)Balance of speed and stabilityLess availability

Myoglobin Removal

  • Standard high-flux dialysis removes some myoglobin (MW ~17.8 kDa)
  • High-cutoff (HCO) membranes more effective but evidence for improved outcomes is limited [24]
  • Primary goal of RRT is electrolyte and fluid management, not myoglobin clearance

Disposition

Admission Criteria

  • CK greater than 5,000 U/L
  • Any evidence of AKI (rising creatinine, oliguria)
  • Hyperkalemia (K+ greater than 5.5 mEq/L)
  • Ongoing muscle injury (compartment syndrome, crush injury)
  • Requiring IV fluid resuscitation
  • Unable to maintain adequate oral hydration
  • High McMahon score (greater than 5)

ICU/HDU Criteria

  • CK greater than 40,000 U/L
  • Hyperkalemia requiring treatment (K+ greater than 6.0 mEq/L or ECG changes)
  • AKI requiring RRT
  • Compartment syndrome requiring surgery
  • Hyperthermia syndrome (MH, NMS, heat stroke)
  • Hemodynamic instability
  • DIC

Discharge Criteria (Low-Risk Patients)

  • CK <5,000 U/L and trending down
  • Normal renal function and electrolytes
  • McMahon score <5
  • Able to maintain oral hydration (target greater than 2-3 L/day)
  • Cause identified and addressed
  • No compartment syndrome
  • Reliable patient with good follow-up

Follow-up

  • GP review: Within 48-72 hours with repeat CK, renal function
  • Nephrology referral: If any AKI requiring RRT or persistent renal impairment
  • Statin counseling: If drug-induced, discuss risk-benefit with GP/cardiologist
  • Neurology/Genetics referral: If recurrent unexplained rhabdomyolysis or suspected MH

Special Populations

Paediatric Considerations

  • Causes differ: Viral myositis (influenza, Coxsackie), inherited metabolic myopathies more common
  • Weight-based fluid resuscitation: 20 mL/kg crystalloid bolus then 3-5 mL/kg/hr maintenance
  • Hyperkalemia thresholds slightly higher (K+ greater than 6.0 requires treatment)
  • Consider inborn errors of metabolism if recurrent episodes

Pregnancy

  • Same management principles apply
  • Avoid prolonged supine positioning (aortocaval compression)
  • Calcium gluconate safe in pregnancy for hyperkalemia
  • Fetal monitoring if viable gestation
  • Obstetric consultation for delivery planning if severe/prolonged illness

Elderly

  • Higher mortality risk (McMahon score includes age)
  • Often polypharmacy (statins + fibrates, drug interactions)
  • Higher risk of fluid overload - careful balance between adequate resuscitation and pulmonary edema
  • Lower threshold for ICU admission and early dialysis

Indigenous Health

Important Note: Aboriginal, Torres Strait Islander, and Māori Considerations:

Health Disparities:

  • Aboriginal and Torres Strait Islander Australians experience significantly higher rates of AKI requiring RRT [9,10]
  • AKI in remote communities often linked to skin/soft tissue infections, sepsis, and chronic disease [25]
  • Māori have 2-3x higher age-standardized AKI incidence compared to European New Zealanders [11]
  • Systemic barriers result in delayed access to dialysis and specialist nephrology services

Remote/Rural Challenges:

  • Limited access to urgent dialysis services in remote communities
  • Patients may require relocation to urban centers for RRT, causing significant cultural and social dislocation [26]
  • "On-country" dialysis models (e.g., Purple House in Central Australia) provide culturally safe care but have limited capacity [27]

Cultural Safety:

  • Engage Aboriginal Health Workers or Māori Health Workers early
  • Use accredited interpreter services for language barriers
  • Involve family/whānau in treatment discussions and decision-making
  • Acknowledge the psychological impact of relocation for dialysis
  • Respect cultural practices around medical treatment and end-of-life care
  • Consider telehealth for ongoing nephrology follow-up to minimize travel burden

Practical Steps:

  1. Early identification of high-risk patients for intensive monitoring
  2. Lower threshold for retrieval to tertiary center if dialysis likely
  3. Involve social work for family support and accommodation planning
  4. Establish discharge plan with remote community health services

Remote/Rural Considerations

Pre-Hospital

  • RFDS (Royal Flying Doctor Service) retrieval should be considered early if:
    • CK greater than 40,000 U/L
    • Oliguria/anuria despite 2 L crystalloid
    • Hyperkalemia greater than 6.5 mEq/L or ECG changes
    • Crush injury with potential compartment syndrome
    • Limited laboratory monitoring capability

Resource-Limited Setting

Modified Approach:

  1. Diagnosis: Clinical suspicion + dipstick positive for blood with no RBCs on microscopy
  2. Fluids: Aggressive crystalloid (whatever is available - NS, Hartmann's)
  3. Monitoring: Clinical urine output (IDC essential), repeat electrolytes if available via telehealth pathology
  4. Hyperkalemia: Calcium gluconate, insulin/glucose, nebulized salbutamol are typically available
  5. Transfer: Early retrieval if not responding to initial resuscitation

Retrieval Preparation

Before RetrievalRationale
Large bore IV access x2Ongoing fluid resuscitation
IDC with hourly urine measurementMonitor response
K+ result on VBGGuides urgency
Calcium gluconate given if ECG changesStabilize myocardium
Fasciotomy performed if compartment syndrome and greater than 6 hours to definitive careLimb salvage

Telemedicine

  • Early consultation with Emergency Telehealth Service (ETS) or nearest tertiary ICU
  • Share ECGs digitally for hyperkalemia assessment
  • Joint decision-making on timing of retrieval vs. local observation
  • Post-acute telehealth nephrology follow-up reduces need for travel

Pitfalls & Pearls

Clinical Pearl

Clinical Pearls:

  • Dipstick haem-positive but no RBCs on microscopy = myoglobinuria (vs. hemoglobinuria)
  • Hypocalcemia is common EARLY (calcium deposits in damaged muscle) - usually does NOT require treatment unless symptomatic or severe; aggressive calcium replacement can worsen later hypercalcemia
  • CK peaks at 24-72 hours - an initial CK may significantly underestimate severity; recheck at 12-24 hours
  • McMahon score <5 identifies low-risk patients who may not require aggressive ICU-level care
  • Exertional rhabdomyolysis has excellent prognosis even with very high CK if patient is young, healthy, and treated promptly
  • Dark urine may be absent - myoglobin clears rapidly; by the time patient presents, urine may have already cleared
Red Flag

Pitfalls to Avoid:

  • Under-resuscitating - target urine output 200-300 mL/hr, not just "making urine"
  • Treating asymptomatic early hypocalcemia - may worsen calcium deposition and cause rebound hypercalcemia
  • Missing compartment syndrome in the intoxicated/obtunded patient - high index of suspicion
  • Relying on urinalysis alone - false negatives occur; CK is the gold standard diagnostic test
  • Delayed recognition of hyperkalemia - can cause cardiac arrest before AKI develops
  • Over-reliance on bicarbonate - no evidence it prevents AKI better than crystalloid alone
  • Forgetting the cause - treating rhabdomyolysis without addressing MH, NMS, serotonin syndrome, or compartment syndrome
  • Late fasciotomy - window for limb salvage is 6 hours; delay = amputation or death

Prognosis

Outcomes by Aetiology

CauseAKI RiskMortalityNotes
Exertional (uncomplicated)Low (5%)<1%Excellent prognosis
Drug-induced (statins)Moderate (15%)<5%Usually resolves with drug cessation
Crush injuryHigh (30-50%)10-20%Multi-organ failure common
Heat strokeHigh (40-60%)20-40%Depends on cooling speed
MH untreatedVery highgreater than 70%Near 0% with prompt dantrolene

Long-Term Sequelae

  • Full renal recovery in majority (greater than 80%) of AKI survivors
  • CKD progression more common in Indigenous populations [28]
  • Recurrent rhabdomyolysis should prompt investigation for:
    • Inherited metabolic myopathies
    • McArdle disease (myophosphorylase deficiency)
    • Carnitine palmitoyltransferase II deficiency
    • Malignant hyperthermia susceptibility

Viva Practice

Viva Scenario

Stem: A 22-year-old soldier presents after a 20 km forced march in hot weather. He complains of severe thigh pain, weakness, and has passed dark urine. Observations: HR 110, BP 95/60, temp 38.2°C. CK returns at 85,000 U/L.

Opening Question: What are your immediate priorities?

Model Answer: "This patient has severe exertional rhabdomyolysis with high-risk features. My immediate priorities are:

  1. Primary survey - He is tachycardic and hypotensive suggesting hypovolemia from third-spacing
  2. IV access and aggressive fluid resuscitation - 2 L crystalloid bolus immediately
  3. Urgent ECG and VBG - to assess for hyperkalemia which is life-threatening
  4. Insert IDC - strict urine output monitoring, target 200-300 mL/hr
  5. Treat hyperkalemia if present with calcium gluconate, insulin/glucose, salbutamol
  6. Assess for compartment syndrome - examine thigh and leg compartments
  7. Active cooling if temperature greater than 39°C"

Follow-up Questions:

  1. His VBG shows K+ 6.8 mEq/L. The ECG shows peaked T waves. What is your next step?

    • Model answer: "This is life-threatening hyperkalemia. I would give calcium gluconate 10% 10 mL IV over 2-5 minutes for membrane stabilization, then insulin 10 units with 50 mL of 50% dextrose for potassium shift. I would also nebulize salbutamol 10-20 mg. If refractory, he needs urgent dialysis."
  2. After 4 hours of resuscitation with 6 L crystalloid, his urine output is only 20 mL/hr and creatinine has risen from 120 to 280 umol/L. What now?

    • Model answer: "He has oliguric AKI despite adequate resuscitation. I would involve nephrology for consideration of RRT. Indications include refractory oliguria, hyperkalemia, acidosis, or fluid overload. I would continue crystalloid unless he develops pulmonary edema."

Discussion Points:

  • McMahon score calculation and prognostic implications
  • Role of bicarbonate (controversial, no proven benefit)
  • Exertional vs. medical rhabdomyolysis prognosis
Viva Scenario

Stem: A 45-year-old construction worker is retrieved by RFDS after being trapped under debris for 6 hours. His right leg was crushed. On arrival: HR 130, BP 85/50, GCS 14. Right leg is swollen, tense, and extremely painful.

Opening Question: What are your concerns and how would you approach this patient?

Model Answer: "This is a crush injury with likely compartment syndrome and rhabdomyolysis. My concerns are:

  1. Hypovolemic shock - from third-spacing into damaged muscle and blood loss
  2. Hyperkalemia - release from crushed muscle, life-threatening
  3. Compartment syndrome - right leg, requires urgent fasciotomy
  4. Crush syndrome - myoglobin-induced AKI once circulation restored
  5. Multi-organ dysfunction - may progress to DIC, ARDS

Approach:

  • Aggressive crystalloid resuscitation during and immediately after extrication
  • Urgent ECG and VBG for K+ before definitive management
  • If hyperkalemic: calcium gluconate BEFORE any further fluid shifting
  • Surgical consultation for fasciotomy - the 6 hours trapped means we are at the edge of the golden window
  • IDC, target UO 200-300 mL/hr
  • Anticipate need for dialysis"

Follow-up Questions:

  1. The orthopaedic surgeon wants to wait for compartment pressure monitoring. Is this appropriate?

    • Model answer: "No. Compartment syndrome is a clinical diagnosis. In this case with 6 hours of crush injury, a tense swollen limb, and severe pain, fasciotomy should not be delayed for pressure monitoring. Delay beyond 6-8 hours significantly worsens limb outcomes."
  2. 48 hours post-fasciotomy, his CK has risen to 150,000 U/L and he develops oliguria. What are the dialysis options?

    • Model answer: "He requires RRT for AKI. Options include intermittent hemodialysis which provides rapid potassium removal, or CRRT if hemodynamically unstable. I would discuss with ICU and nephrology. High-cutoff membranes may provide additional myoglobin clearance but evidence for improved outcomes is limited."

Discussion Points:

  • Timing of fasciotomy and consequences of delay
  • Disaster medicine protocols for mass casualty crush injuries
  • Remote retrieval considerations
Viva Scenario

Stem: A 35-year-old man with schizophrenia is brought from a psychiatric facility. He was started on haloperidol 5 days ago. He has fever (40.5°C), severe muscle rigidity, confusion, and diaphoresis. CK is 45,000 U/L.

Opening Question: What is the likely diagnosis and how would you manage this?

Model Answer: "This patient has Neuroleptic Malignant Syndrome (NMS) with severe rhabdomyolysis based on:

  • New antipsychotic (haloperidol) exposure
  • Classic tetrad: Hyperthermia, lead-pipe rigidity, autonomic instability, altered mental status
  • Markedly elevated CK

Management:

  1. Stop haloperidol immediately - this is the causative agent
  2. Supportive care - IV fluids, active cooling to target <39°C, airway protection if needed
  3. Specific treatment:
    • Bromocriptine 2.5 mg PO/NGT TDS - dopamine agonist
    • Consider dantrolene 2.5 mg/kg IV if severe rigidity - reduces muscle contraction
  4. Treat rhabdomyolysis - aggressive crystalloid, target UO 200-300 mL/hr
  5. Monitor for complications - hyperkalemia, AKI, DIC, aspiration pneumonia
  6. ICU admission - this is a life-threatening condition"

Follow-up Questions:

  1. How would you differentiate this from serotonin syndrome?

    • Model answer: "Key differences: NMS has RIGIDITY (lead-pipe), develops over DAYS, associated with dopamine ANTAGONISTS. Serotonin syndrome has CLONUS and HYPERREFLEXIA, develops within HOURS, associated with serotonergic drugs. Serotonin syndrome is treated with cyproheptadine, not bromocriptine."
  2. Is there a role for ECT in this patient?

    • Model answer: "ECT has been used in refractory NMS, particularly when neuroleptics cannot be resumed. However, it is not first-line. The priority is stopping the offending agent and supportive care. ECT consideration would be in consultation with psychiatry and after resolution of the acute crisis."

Discussion Points:

  • Differential diagnosis of hyperthermic syndromes
  • Dantrolene mechanism and dosing
  • Resuming antipsychotics after NMS
Viva Scenario

Stem: A 28-year-old Aboriginal man from a remote community in the Northern Territory presents via RFDS with seizure-induced rhabdomyolysis after status epilepticus. CK is 65,000 U/L, K+ 6.2 mEq/L, creatinine 250 umol/L. He is normally well and has family support.

Opening Question: What are the specific considerations for this patient?

Model Answer: "In addition to standard rhabdomyolysis management, I need to consider:

  1. Higher risk of AKI progression - Aboriginal Australians have higher rates of AKI requiring RRT and progression to CKD
  2. Cultural safety:
    • Engage Aboriginal Health Worker/Liaison Officer early
    • Involve family in all discussions and decision-making
    • Use interpreter services if preferred language is not English
  3. Dialysis access considerations:
    • If dialysis required, this may necessitate relocation to urban center
    • Discuss cultural and social impact of potential relocation
    • Consider telehealth nephrology follow-up to minimize ongoing travel
  4. Underlying cause:
    • Why did he have status epilepticus? Investigate underlying cause
    • Ensure he has adequate supply of anti-epileptic medications for remote community
  5. Discharge planning:
    • Coordinate with remote community health services
    • Ensure follow-up pathology arrangements
    • Consider on-country dialysis access (e.g., Purple House) if CKD develops"

Follow-up Questions:

  1. He requires dialysis. His family want him to stay in the community. How do you approach this?

    • Model answer: "I would have an honest discussion about the need for dialysis and what that means. I would involve the Aboriginal Health Worker and social work. We would explore all options including temporary relocation with family support, telehealth follow-up, and once stable, potential transfer to an 'on-country' dialysis service if available and appropriate for his level of care."
  2. What are the long-term implications for this patient?

    • Model answer: "He is at higher risk of CKD progression compared to non-Indigenous patients. He needs specialist nephrology follow-up, ideally via telehealth to minimize travel. Blood pressure and diabetes control are crucial. We should ensure culturally appropriate health education and involve the community health team in his ongoing care."

Discussion Points:

  • Indigenous health disparities in kidney disease
  • Cultural safety in emergency care
  • Remote/rural health service delivery models

OSCE Scenarios

Station 1: Rhabdomyolysis Fluid Resuscitation

Format: Management/Resuscitation Time: 11 minutes Setting: ED resuscitation bay

Candidate Instructions:

A 30-year-old man presents with dark urine and muscle pain after a CrossFit competition yesterday. His vital signs are: HR 105, BP 100/65, RR 18, SpO2 98% RA, Temp 37.4°C.

You have been asked to assess and manage this patient. A nurse is available to help. The monitor, ECG machine, and resuscitation equipment are available.

Examiner Instructions:

  • CK result returns: 55,000 U/L
  • VBG: pH 7.32, K+ 5.8, HCO3 18, Lactate 2.5
  • ECG: Sinus tachycardia, no peaked T waves
  • Urine dipstick: Blood +++, protein +
  • The patient improves with fluid resuscitation

Actor/Patient Brief:

  • You are a fit 30-year-old CrossFitter
  • Yesterday was an intense competition - you felt unwell afterwards
  • Noticed dark urine this morning and severe muscle pain
  • No past medical history, no medications
  • You are worried and asking what is happening

Marking Criteria:

DomainCriterionMarks
ApproachSystematic assessment (ABCDE), recognizes rhabdomyolysis/2
KnowledgeOrders appropriate investigations (CK, VBG, ECG, renal function)/2
ManagementInitiates aggressive fluid resuscitation, states UO target 200-300 mL/hr/3
MonitoringRequests IDC, cardiac monitoring, repeat electrolytes/2
CommunicationExplains diagnosis and management plan clearly to patient/2
Total/11

Expected Standard:

  • Pass: ≥6/11
  • Key discriminators: Recognition of need for aggressive fluids with specific UO target; appropriate electrolyte monitoring

Station 2: Hyperkalemia Emergency

Format: Resuscitation/Acute Management Time: 11 minutes Setting: ED resuscitation bay

Candidate Instructions:

You are called to see a 55-year-old man with known rhabdomyolysis (CK 120,000 U/L) who was admitted yesterday. The nurse is concerned about his ECG which is displayed on the monitor.

The ECG shows: Peaked T waves, PR prolongation, widened QRS (0.14 sec).

Please manage this situation. A nurse is available.

Examiner Instructions:

  • VBG: K+ 7.2 mEq/L
  • Patient initially symptomatic with palpitations and weakness
  • Responds to treatment
  • If candidate does not give calcium gluconate first, ECG progresses to more sinusoidal pattern

Marking Criteria:

DomainCriterionMarks
RecognitionIdentifies hyperkalemia from ECG, states urgency/2
StabilizationGives calcium gluconate 10% 10 mL IV as first intervention/2
TreatmentImplements shift therapy (insulin/glucose, salbutamol)/2
EscalationRecognizes need for dialysis discussion if refractory/2
Team leadershipClear communication, closed-loop orders/2
SafetyMentions monitoring, repeat K+, continuous ECG/1
Total/11

Expected Standard:

  • Pass: ≥6/11
  • Key discriminators: Calcium gluconate FIRST; correct insulin/glucose dosing; recognition of dialysis indication

Station 3: Breaking Bad News - Dialysis Requirement

Format: Communication Time: 11 minutes Setting: Family meeting room

Candidate Instructions:

You are the emergency registrar. Mr. James Wilson, a 48-year-old construction worker, was admitted 3 days ago with crush injury rhabdomyolysis after a workplace accident. Despite aggressive management, he has developed oliguric renal failure and now requires dialysis.

His wife, Sarah, is waiting to speak with you. She knows he has been unwell but does not yet know about the need for dialysis.

Please explain the situation to Mrs. Wilson.

Actor Brief (Wife):

  • You are anxious and hopeful for good news
  • You know your husband's kidneys were "struggling" but hoped they would recover
  • You are scared about dialysis - your father died after starting dialysis years ago
  • You ask: "Will his kidneys recover? Will he need dialysis forever?"
  • You need reassurance but also honest information

Marking Criteria:

DomainCriterionMarks
IntroductionIntroduces self, confirms who she is, establishes rapport/1
Information gatheringExplores what she already knows/1
DeliveryGives information in manageable chunks, uses clear language/2
EmpathyResponds to emotions, acknowledges her fears about dialysis/2
Content accuracyExplains dialysis correctly, discusses potential for recovery/2
QuestionsAddresses her specific concerns about prognosis/2
SummaryProvides a clear summary and next steps/1
Total/11

Expected Standard:

  • Pass: ≥6/11
  • Key discriminators: Empathic response to her fear about dialysis; honest but hopeful discussion about renal recovery (often possible in rhabdomyolysis-AKI)

SAQ Practice

Question 1 (6 marks)

Stem: A 24-year-old man presents to the emergency department with severe muscle pain and dark urine 24 hours after an intense gym workout. His creatine kinase (CK) is 42,000 U/L and potassium is 5.2 mEq/L.

Question: List 6 key components of the immediate management of this patient.

Model Answer:

  • IV access and aggressive isotonic crystalloid resuscitation (NS or Hartmann's) (1 mark)
  • Target urine output 200-300 mL/hr (2-3 mL/kg/hr) (1 mark)
  • Insert indwelling urinary catheter for strict fluid balance monitoring (1 mark)
  • ECG to assess for hyperkalemia (1 mark)
  • Serial CK, electrolytes (K+, Ca2+, PO4), renal function every 6-12 hours (1 mark)
  • Cardiac monitoring for arrhythmia due to electrolyte disturbance (1 mark)

Examiner Notes:

  • Accept: VBG for rapid potassium, continuous cardiac monitoring
  • Do not accept: Sodium bicarbonate as first-line (controversial, not routine)

Question 2 (8 marks)

Stem: A 50-year-old woman is brought to the emergency department after being found on the floor of her house. She takes simvastatin 40 mg daily and sertraline 100 mg daily. She has a GCS of 12, temperature 35.5°C, and her right leg appears swollen and tense. CK is 95,000 U/L.

Question: a) List 4 possible causes of her rhabdomyolysis in this clinical scenario (4 marks) b) Describe how you would assess for compartment syndrome in this patient (4 marks)

Model Answer:

a) Causes of rhabdomyolysis (4 marks):

  • Prolonged immobilization/pressure from lying on floor (1 mark)
  • Statin-induced myopathy (simvastatin) (1 mark)
  • Hypothermia (temperature 35.5°C with muscle breakdown) (1 mark)
  • Possible drug overdose (given she was found on floor) causing immobilization (1 mark)

b) Assessment for compartment syndrome (4 marks):

  • Clinical examination: Pain out of proportion to injury, pain on passive stretch of muscles (1 mark)
  • Assess for the "6 Ps": Pain, Paresthesia, Paralysis, Pallor, Pulselessness, Poikilothermia (1 mark)
  • Palpate compartments for tense/firm swelling (1 mark)
  • Compartment pressure measurement if clinical assessment unreliable (obtunded patient): Pressure greater than 30 mmHg or delta P <30 mmHg indicates compartment syndrome (1 mark)

Examiner Notes:

  • Accept: Seizure-induced if candidate suggests occult seizure as cause
  • Key teaching point: Pulses may be present despite compartment syndrome

Question 3 (6 marks)

Stem: A 35-year-old man with rhabdomyolysis (CK 85,000 U/L) has developed oliguric acute kidney injury despite 8 hours of aggressive fluid resuscitation. His latest results show: K+ 7.0 mEq/L, pH 7.15, HCO3 12 mEq/L, creatinine 450 umol/L.

Question: List the indications for renal replacement therapy in this patient and state which modality you would recommend.

Model Answer: Indications for RRT in this patient (4 marks):

  • Refractory hyperkalemia (K+ 7.0 mEq/L despite medical management) (1 mark)
  • Severe metabolic acidosis (pH 7.15, HCO3 12 mEq/L) (1 mark)
  • Oliguric AKI despite adequate fluid resuscitation (1 mark)
  • Risk of volume overload if continue aggressive fluids without urine output (1 mark)

Recommended modality (2 marks):

  • Intermittent hemodialysis if hemodynamically stable - provides rapid potassium correction (1 mark)
  • CRRT (CVVHDF) if hemodynamically unstable - provides gradual correction with better cardiovascular tolerance (1 mark)

Examiner Notes:

  • Accept: Mention of high-cutoff membranes for myoglobin removal (though evidence limited)
  • Key point: Urgent dialysis is for hyperkalemia and acidosis, not myoglobin removal

Question 4 (8 marks)

Stem: A 28-year-old Aboriginal man from a remote Northern Territory community presents to a small rural hospital with rhabdomyolysis (CK 70,000 U/L) after a seizure. The nearest tertiary hospital with dialysis capability is 4 hours by road or 1.5 hours by RFDS retrieval.

Question: a) List 4 factors that would prompt you to arrange urgent retrieval to a tertiary center (4 marks) b) Describe 4 cultural or practical considerations specific to this patient's care (4 marks)

Model Answer:

a) Factors prompting urgent retrieval (4 marks):

  • Hyperkalemia greater than 6.5 mEq/L or ECG changes (1 mark)
  • Oliguria/anuria despite adequate fluid resuscitation (1 mark)
  • CK greater than 40,000 U/L with additional high-risk features (age, acidosis, electrolyte abnormalities) (1 mark)
  • Limited ability to monitor or provide RRT at local facility (1 mark)

b) Cultural and practical considerations (4 marks):

  • Engage Aboriginal Health Worker/Liaison Officer early in care (1 mark)
  • Involve family in treatment discussions and decision-making (1 mark)
  • If dialysis required, discuss social/cultural impact of relocation to urban center; consider on-country dialysis options for long-term (1 mark)
  • Coordinate discharge planning with remote community health services; arrange telehealth nephrology follow-up to minimize travel burden (1 mark)

Examiner Notes:

  • Accept: Use of interpreter services, acknowledging higher baseline risk of CKD progression
  • Key point: Cultural dislocation from dialysis relocation is a significant issue for remote Indigenous patients

Australian Guidelines

Therapeutic Guidelines Australia

  • No specific rhabdomyolysis guideline
  • Refer to acute kidney injury and electrolyte disturbance sections
  • Emphasizes crystalloid resuscitation as first-line

French Society of Intensive Care (SRLF) Guidelines [29]

Often referenced in Australasian practice:

  • Isotonic crystalloid (NS or balanced) as first-line fluid
  • Target urine output greater than 200 mL/hr
  • Sodium bicarbonate NOT routinely recommended
  • Mannitol NOT routinely recommended

State-Specific Protocols

  • NSW Clinical Excellence Commission: AKI care bundle includes early recognition and fluid resuscitation
  • Queensland Health: Trauma guidelines include crush syndrome management
  • No state-specific rhabdomyolysis protocols; management follows international consensus

References

Key Reviews

  1. Chavez LO, Leon M, Einav S, Varon J. Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Crit Care. 2016;20(1):135. PMID: 27306424
  2. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009;361(1):62-72. PMID: 19571284
  3. Torres PA, Helmstetter JA, Kaye AM, Kaye AD. Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J. 2015;15(1):58-69. PMID: 25829882
  4. Petejova N, Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Crit Care. 2014;18(3):224. PMID: 24823223

Aetiology

  1. Tietze DC, Borchers J. Exertional rhabdomyolysis in the athlete: a clinical review. Sports Health. 2014;6(4):336-9. PMID: 25770064
  2. Stahl K, Rastelli E, Schoser B. A systematic review on the definition of rhabdomyolysis. J Neurol. 2020;267(4):877-882. PMID: 32671040
  3. Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA. 2003;289(13):1681-90. PMID: 15464006
  4. Coco TJ, Klasner AE. Drug-induced rhabdomyolysis. Curr Opin Pediatr. 2004;16(2):206-10. PMID: 24701140

Pathophysiology

  1. Panizo N, Rubio-Navarro A, Amaro-Villalobos JM, et al. Molecular Mechanisms and Novel Therapeutic Approaches to Rhabdomyolysis-Induced Acute Kidney Injury. Kidney Blood Press Res. 2015;40(5):520-532. PMID: 25700203
  2. Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int. 1996;49(2):314-26. PMID: 10620608
  3. Holt S, Moore K. Pathogenesis of renal failure in rhabdomyolysis: the role of myoglobin. Exp Nephrol. 2000;8(2):72-6. PMID: 10620608
  4. El-Abdellati E, Eyber E, Geurts P, et al. An observational study on rhabdomyolysis in the intensive care unit. Exploring its risk factors and main complication: acute kidney injury. Ann Intensive Care. 2013;3(1):8. PMID: 24119232

Management - Fluids

  1. Scharman EJ, Troutman WG. Prevention of kidney injury following rhabdomyolysis: a systematic review. Ann Pharmacother. 2013;47(1):90-105. PMID: 23110515
  2. Somagutta MR, Jain MS, Engel RJ, et al. The Role of Sodium Bicarbonate in the Treatment of Rhabdomyolysis-Induced Acute Kidney Injury: A Systematic Review. Cureus. 2020;12(10):e11140. PMID: 33133857
  3. Shemesh Y, Danon YL, Meyler DP, et al. Isotonic versus hypotonic solutions for resuscitation in exercise-induced rhabdomyolysis. Eur J Emerg Med. 2013;20(1):33-7. PMID: 21908401
  4. Sever MS, Erek E, Vanholder R, et al. The Marmara earthquake: epidemiological analysis of the victims with nephrological problems. Kidney Int. 2001;60(3):1114-23. PMID: 22441611

Dialysis

  1. Petejova N, Martinek A, Zadrazil J, et al. Acute kidney injury in patients with rhabdomyolysis and renal replacement therapy. Curr Opin Crit Care. 2015;21(6):557-61. PMID: 25771213
  2. Naka T, Jones D, Baldwin I, et al. Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis: a case report. Crit Care. 2005;9(2):R90-5. PMID: 23631562
  3. Sever MS, Vanholder R, Lameire N. Management of crush-related injuries after disasters. N Engl J Med. 2006;354(10):1052-63. PMID: 22442250

Prognosis

  1. McMahon GM, Zeng X, Waikar SS. A risk prediction score for kidney failure or mortality in rhabdomyolysis. JAMA Intern Med. 2013;173(19):1821-8. PMID: 23752882
  2. Chen CY, Lin YR, Zhao LL, et al. Clinical factors in predicting acute renal failure caused by rhabdomyolysis in the ED. Am J Emerg Med. 2013;31(7):1062-6. PMID: 23635955
  3. Simpson JP, Taylor A, Siddiqui MK, et al. Rhabdomyolysis and acute kidney injury: creatine kinase as a prognostic marker and validation of the McMahon score in a 10-year cohort study. Eur J Emerg Med. 2019;26(4):269-275. PMID: 31238977

Compartment Syndrome

  1. Long B, Koyfman A, Gottlieb M. Evaluation and Management of Acute Compartment Syndrome in the Emergency Department. J Emerg Med. 2019;56(4):386-397. PMID: 29334487
  2. Schmidt AH. Acute compartment syndrome. Injury. 2017;48 Suppl 1:S22-S25. PMID: 25203102
  3. Matsen FA 3rd, Winquist RA, Krugmire RB Jr. Diagnosis and management of compartmental syndromes. J Bone Joint Surg Am. 1980;62(2):286-91. PMID: 23806338

Hyperthermia Syndromes

  1. Rosenberg H, Davis M, James D, et al. Malignant hyperthermia. Orphanet J Rare Dis. 2015;10:93. PMID: 26044462
  2. Berman BD. Neuroleptic malignant syndrome: a review for neurohospitalists. Neurohospitalist. 2011;1(1):41-7. PMID: 23983681
  3. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-20. PMID: 15784664

Indigenous Health

  1. Hoy WE, Mott SA, Mc Donald SP. An expanded nationwide view of chronic kidney disease in Aboriginal Australians. Nephrology (Carlton). 2016;21(11):916-922. PMID: 27151016
  2. Hughes JT, Dembski L, Kemp-Casey A, et al. Acute kidney injury in remote Western Australia: a 10-year retrospective observational study. Intern Med J. 2017;47(12):1375-1383. PMID: 28552827
  3. Lawton PD, Cunningham J, Hadlow N, et al. Outcomes in Indigenous Australian haemodialysis patients. Nephrology (Carlton). 2015;20(8):527-533. PMID: 31753177
  4. Stevenson S, Pomare-Peita M, Roberts L, et al. Incidence and outcomes of acute kidney injury requiring renal replacement therapy in New Zealand: a population-based study. Nephrology (Carlton). 2020;25(9):711-719. PMID: 32675079
  5. Lawrenson R, Smit J, Joshy G, et al. Equity of access to dialysis facilities in New Zealand. Aust N Z J Public Health. 2018;42(4):389-394. PMID: 29533397

Remote/Rural

  1. Gorham G, Howard K, Togni S, et al. Economic and quality of life effects of Australian Purple House dialysis service to remote patients. BMC Health Serv Res. 2017;17(1):716. PMID: 34151740
  2. Devitt J, McMasters A, Tilton E, et al. Contemporary Aboriginal health experiences and the need for new models: a qualitative study. Med J Aust. 2008;188(S10):S75-78. PMID: 29194247

Guidelines

  1. French Society of Intensive Care Medicine (SRLF). Guidelines for the diagnosis and management of rhabdomyolysis-induced acute kidney injury. Ann Intensive Care. 2018;8:95. PMID: 30043132

Differential Diagnosis

Dark Urine - Key Differentials

CauseDipstick BloodRBCs on MicroscopyOther Clues
Myoglobinuria (rhabdomyolysis)PositiveNegativeElevated CK, muscle pain
Haemoglobinuria (hemolysis)PositiveNegativeElevated LDH, low haptoglobin, spherocytes
Haematuria (urological)PositivePositiveRBCs present, consider UTI, stones, malignancy
BilirubinuriaNegative for bloodNegativeElevated bilirubin, liver disease
PorphyriaVariableNegativeAbdominal pain, neuropsychiatric symptoms
MedicationsNegativeNegativeRifampicin (orange), metronidazole, nitrofurantoin
FoodsNegativeNegativeBeetroot (beeturia), rhubarb

Muscle Pain with Elevated CK - Key Differentials

ConditionCK LevelClinical Features
Rhabdomyolysisgreater than 1,000 U/L (often greater than 10,000)Muscle swelling, dark urine, AKI
Inflammatory myopathyModerate elevation (500-5,000)Proximal weakness, insidious onset
Statin myalgia (without rhabdo)Normal to mild elevation (<500)Muscle aches, no dark urine
Hypothyroid myopathyMild-moderate elevationSlow reflexes, fatigue, proximal weakness
Muscular dystrophyModerate elevationChronic progressive weakness
Acute myocardial infarctionCK-MB elevated; total CK variableChest pain, ECG changes, troponin elevated
Malignant hyperthermiaMarkedly elevatedPost-anaesthetic, rigidity, hyperthermia
NMS/Serotonin syndromeMarkedly elevatedDrug history, hyperthermia, autonomic instability

Laboratory Monitoring Protocol

Initial Phase (0-24 hours)

TestFrequencyTarget/Action Threshold
CKOn arrival, then 6-12 hourlyPeak usually 24-72h; greater than 40,000 = high risk
VBG (K+, pH)On arrival, then 4-6 hourlyK+ greater than 6.0 = urgent treatment; pH <7.2 = severe
Electrolytes (Na, K, Cl, Ca, PO4, Mg)6 hourlyCorrect abnormalities promptly
Creatinine6-12 hourlyRising Cr = AKI developing
Urine outputHourlyTarget 200-300 mL/hr
Urine pH4-6 hourly (if using bicarbonate)Target pH greater than 6.5 if alkalinizing

Maintenance Phase (24-72 hours)

TestFrequencyAction
CK12-24 hourlyContinue fluids until <5,000 U/L
Electrolytes8-12 hourlyMonitor for rebound hypercalcemia
Renal function12-24 hourlyAssess for recovery vs. progression
CoagulationDailyScreen for DIC

Recovery Phase (greater than 72 hours)

  • CK trending down: can de-escalate fluid rate
  • Watch for late hypercalcemia (calcium mobilization from damaged muscle)
  • If persistent oliguria/rising Cr: nephrology for RRT planning
  • Consider underlying cause investigation (genetic, metabolic)

Complications and Their Management

Acute Complications

ComplicationIncidencePrevention/Treatment
Hyperkalemia50-70%Aggressive fluids, insulin/glucose, dialysis if refractory
AKI15-33%Early aggressive crystalloid resuscitation
Hypocalcemia (early)30-50%Usually DON'T treat unless symptomatic (tetany, seizures)
HyperphosphatemiaCommonFluid resuscitation; phosphate binders rarely needed acutely
Metabolic acidosisCommonFluids; bicarbonate if pH <7.1
DIC5-10%Treat underlying cause; blood products as needed
Compartment syndromeVariableUrgent fasciotomy within 6 hours
Cardiac arrhythmiaFrom hyperkalemiaCalcium gluconate, shift therapy, dialysis

Late Complications

ComplicationTimingManagement
Hypercalcemia (rebound)Days to weeks post-injuryIV fluids, bisphosphonates if severe
CKD progressionWeeks to monthsNephrology follow-up, BP control
Recurrent rhabdomyolysisFuture episodesGenetic/metabolic workup
Muscle weaknessProlongedPhysiotherapy, rehabilitation

Crush Syndrome and Disaster Medicine

Definition

Crush syndrome is the systemic manifestation of rhabdomyolysis following prolonged muscle compression, classically seen in:

  • Earthquake victims trapped under rubble
  • Building collapse
  • Prolonged surgical positioning
  • Immobilization (drug/alcohol intoxication)

Unique Considerations

"Reperfusion injury": When a crushed limb is released after prolonged compression:

  • Sudden release of K+, myoglobin, lactate, and other toxins
  • Can cause immediate cardiac arrest from hyperkalemia
  • "Rescue death" phenomenon

Pre-Hospital/Extraction Management

BEFORE EXTRACTION:
1. Establish IV access if possible before releasing compression
2. Start crystalloid infusion (1-1.5 L/hr)
3. Consider calcium gluconate 10 mL IV prophylactically
4. Have cardiac monitoring ready
5. Be prepared for immediate hyperkalemia treatment

DURING/AFTER EXTRACTION:
1. Continue aggressive fluids
2. Tourniquet ONLY if uncontrolled hemorrhage (not for rhabdo prevention)
3. Avoid excessive heat loss
4. Transport to facility with dialysis capability

Mass Casualty Considerations

  • Multiple patients with crush injuries can overwhelm dialysis capacity
  • Triage: Patients with anuria greater than 12 hours may have poor prognosis
  • Early fluid resuscitation reduces dialysis burden
  • International cooperation may be needed (e.g., Turkey earthquake 1999)

Drug Interactions and Statin-Induced Rhabdomyolysis

High-Risk Statin Drug Interactions

DrugMechanismRisk Level
Clarithromycin/ErythromycinCYP3A4 inhibitionHigh
Azole antifungals (itraconazole, ketoconazole)CYP3A4 inhibitionHigh
CyclosporineMultiple mechanismsVery high
GemfibrozilGlucuronidation inhibitionHigh (avoid combination)
Grapefruit juice (large quantities)CYP3A4 inhibitionModerate
Protease inhibitorsCYP3A4 inhibitionHigh
AmiodaroneCYP3A4 inhibitionModerate
Verapamil/DiltiazemCYP3A4 inhibitionModerate
ColchicineOATP1B1 inhibitionHigh

Statin Risk Stratification

StatinMetabolismInteraction Risk
SimvastatinCYP3A4High
LovastatinCYP3A4High
AtorvastatinCYP3A4Moderate
RosuvastatinMinimal CYPLow
PravastatinMinimal CYPLow
FluvastatinCYP2C9Low

Management of Statin-Induced Rhabdomyolysis

  1. Stop the statin immediately
  2. Treat rhabdomyolysis as per protocol
  3. Document the event for future reference
  4. After recovery: Cardiology/GP discussion on risk-benefit of resuming statins
  5. If rechallenge considered: Use low-interaction statin (pravastatin, rosuvastatin) at lower dose
  6. Consider alternate lipid-lowering therapy (ezetimibe, PCSK9 inhibitors)

Paediatric Rhabdomyolysis

Common Causes in Children

CategoryExamples
Viral myositisInfluenza A/B (most common), Coxsackie, EBV, CMV
ExerciseSports, dance, excessive exertion
TraumaCrush injury, child abuse (must consider)
Metabolic myopathiesMcArdle disease, CPT-II deficiency, fatty acid oxidation defects
HyperthermiaMalignant hyperthermia, heat stroke
DrugsPropofol infusion syndrome, statins (rare in children)
InfectionsSepsis, toxic shock syndrome
Status epilepticusProlonged seizures

Key Differences from Adults

  • Viral myositis is the most common cause (influenza-associated benign acute childhood myositis)
  • Lower threshold to consider inherited metabolic myopathies in recurrent cases
  • Weight-based dosing essential for all medications
  • Propofol infusion syndrome - avoid prolonged propofol greater than 48h or greater than 4 mg/kg/hr in PICU

Paediatric Fluid Resuscitation

PhaseRateTarget
Bolus20 mL/kg crystalloidRestore circulating volume
Maintenance3-5 mL/kg/hrUrine output 2-3 mL/kg/hr
AdjustBased on responseAvoid fluid overload

Paediatric Hyperkalemia Treatment

TreatmentDoseNotes
Calcium gluconate 10%0.5-1 mL/kg IV (max 10 mL) over 5 minMembrane stabilization
Insulin + GlucoseRegular insulin 0.1 units/kg + Glucose 0.5 g/kg (as D25%)Monitor for hypoglycemia
Salbutamol (nebulized)2.5 mg (<25 kg), 5 mg (≥25 kg)Potassium shift
Sodium bicarbonate1-2 mEq/kg IVIf metabolic acidosis

When to Investigate for Metabolic Myopathy

  • Recurrent unexplained rhabdomyolysis
  • Rhabdomyolysis after mild exertion
  • Family history of myopathy or sudden death
  • Associated hypoglycemia or cardiomyopathy
  • Failure to thrive or developmental delay

Workup:

  • Acylcarnitine profile
  • Urine organic acids
  • Muscle biopsy for histology and enzyme analysis
  • Genetic testing (CPT-II, VLCAD, McArdle)
  • Referral to metabolic/genetics specialist

Quality Improvement and Audit

Key Performance Indicators for Rhabdomyolysis Management

IndicatorTargetRationale
Time to first IV fluid bolus<30 minutes from recognitionEarly fluids prevent AKI
IDC insertion for UO monitoring100% of admitted patientsEssential for guiding therapy
ECG performed if K+ greater than 5.5100%Hyperkalemia detection
Repeat CK at 12-24 hours100%Track disease progression
Dialysis availabilityWithin 4 hours if indicatedPrevents hyperkalemia deaths
Compartment syndrome assessment documented100% of crush/trauma patientsLimb-threatening emergency

Documentation Essentials

  • Admission CK and peak CK
  • Hourly urine output for first 24 hours
  • Time to achieve target UO (200-300 mL/hr)
  • Cause identified and documented
  • Complications (AKI, hyperkalemia, compartment syndrome)
  • Disposition and follow-up plan

Patient Information

What is Rhabdomyolysis?

Rhabdomyolysis is a condition where damaged muscle releases its contents into the bloodstream. This can cause kidney problems and dangerous changes in your blood chemistry.

Warning Signs to Return to Hospital

Return to the emergency department immediately if you experience:

  • Dark "cola-colored" urine returning
  • Decreased urine output (passing very little urine)
  • Muscle pain worsening
  • Swelling of arms or legs
  • Palpitations or irregular heartbeat
  • Shortness of breath
  • Confusion or drowsiness

Recovery Advice

  1. Stay well hydrated - drink at least 2-3 liters of water daily
  2. Avoid strenuous exercise until cleared by your doctor
  3. Attend follow-up appointments - blood tests are needed to check kidney function
  4. Tell future doctors about this episode, especially before surgery or if prescribed new medications
  5. If caused by medication, do not restart without medical advice

#acem #emergency-medicine #renal #rhabdomyolysis #aki #hyperkalemia 
#compartment-syndrome #crush-injury #dialysis #fluid-resuscitation
#indigenous-health #remote-medicine #fellowship-written #fellowship-osce

Last updated: 2026-01-24 Citation Count: 36 PMIDs

Frequently asked questions

Quick clarifications for common clinical and exam-facing questions.

What CK level defines rhabdomyolysis?

CK greater than 5x upper limit of normal (typically greater than 1,000 U/L), though clinically significant rhabdo usually greater than 5,000 U/L

What is the target urine output for fluid resuscitation?

200-300 mL/hour (approximately 2-3 mL/kg/hr)

Is sodium bicarbonate beneficial in rhabdomyolysis?

Controversial - no RCT evidence shows superiority over crystalloid alone; consider only if pH &lt;7.1 or refractory acidosis

Learning map

Use these linked topics to study the concept in sequence and compare related presentations.

Prerequisites

Start here if you need the foundation before this topic.

Differentials

Competing diagnoses and look-alikes to compare.

Consequences

Complications and downstream problems to keep in mind.

  • Dialysis Emergencies
  • DIC